Search

Your search keyword '"Kvedariene V"' showing total 425 results

Search Constraints

Start Over You searched for: Author "Kvedariene V" Remove constraint Author: "Kvedariene V"
425 results on '"Kvedariene V"'

Search Results

1. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

3. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

4. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

6. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

7. Correction to: Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

8. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

9. Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

10. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

11. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

12. Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

13. The ARIA-MeDALL hypothesis

14. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

15. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

16. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

17. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

18. Indoor air pollution effects on pediatric asthma are submicron aerosol particle–dependent

19. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

20. Work productivity in rhinitis using cell phones: The MASK pilot study

21. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

22. Development and validation of combined symptom-medication scores for allergic rhinitis*

23. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model

24. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air® real-world data

25. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

26. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

27. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

28. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

29. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

30. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

31. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

32. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

33. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

34. Management of anaphylaxis due to COVID-19 vaccines in the elderly

35. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

36. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper

37. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

38. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

39. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

40. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

41. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

42. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

43. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

44. Treatment of allergic rhinitis during and outside the pollen season using mobile technology : A MASK study

45. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

46. Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report

47. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project

49. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases

50. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

Catalog

Books, media, physical & digital resources